<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383561</url>
  </required_header>
  <id_info>
    <org_study_id>KAEK-92</org_study_id>
    <nct_id>NCT04383561</nct_id>
  </id_info>
  <brief_title>Relationship Between LRG and Periodontal Disease</brief_title>
  <official_title>Leucin-rich alpha2 Glycoprotein (LRG): A Novel Acute Phase Protein Related With Stage 3 Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aydin Adnan Menderes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Giresun University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aydin Adnan Menderes University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to investigate gingival crevicular fluid (GCF) and serum levels of LRG,
      interleukin (IL)-6 and tumor necrosis factor (TNF)-α in patients with periodontitis before
      and after non-surgical periodontal treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-five stage 3 periodontitis and twenty-five periodontally healthy individuals were
      enrolled in the study. Clinical periodontal measurements were recorded; periodontitis
      patients received non-surgical periodontal treatment, and GCF and serum samples were obtained
      at baseline and at 6 weeks after treatment. LRG, IL-6 and TNF-α were determined by ELISA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Actual">February 15, 2020</completion_date>
  <primary_completion_date type="Actual">January 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the levels of biochemical parameters</measure>
    <time_frame>Baseline and 6 weeks after treatment</time_frame>
    <description>The levels LRG, IL-6 and TNF-α were determined to define the diagnostic and prognostic potential as a biomarker in periodontitis.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Periodontitis</condition>
  <condition>Acute-Phase Response</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>stage 3 periodontitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GCF and serum samples were collected before and after treatment from periodontitis patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontally healthy controls</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>GCF and serum samples were collected from periodontally healthy controls at baseline for once.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-surgical periodontal treatment</intervention_name>
    <description>Scaling and root planing (SRP), in four clinical visits</description>
    <arm_group_label>stage 3 periodontitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral hygiene instructions</intervention_name>
    <description>Oral hygiene instructions includes brushing with the modified Bass technique, interdental cleaning with dental floss and interdental brushes.</description>
    <arm_group_label>Periodontally healthy controls</arm_group_label>
    <arm_group_label>stage 3 periodontitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 25-50 years of age

          2. having at least 20 natural teeth, excluding third molars

          3. having no systemic disease

          4. non-smokers

          5. criteria for healthy control group: BOP &lt; 10% and PD ≤ 3 mm without clinical
             attachment loss or radiographic sign of alveolar bone destruction

          6. criteria for stage 3 periodontitis group: interdental CAL ≥ 5 mm at least 2
             non-adjacent teeth, PD ≥ 6 mm and radiographic bone loss extending to the mid-third of
             the root or beyond.

        Exclusion Criteria:

          1. having any systemic diseases,

          2. smoking

          3. current pregnancy or lactation

          4. a history of periodontal treatment in the past 6 months

          5. using antibiotic, anti-inflammatory drugs or any other drugs within the past 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Giresun University</name>
      <address>
        <city>Giresun</city>
        <zip>28100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Giresun University</investigator_affiliation>
    <investigator_full_name>Zeynep Pinar KELES YUCEL</investigator_full_name>
    <investigator_title>Assistant Prof.</investigator_title>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>gingival crevicular fluid</keyword>
  <keyword>serum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Acute-Phase Reaction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

